Abstract
Lysophospholipids may play an important protective role during primary infection of Mycobacterium tuberculosis (MTB) by enhancing innate antimycobacterial immune response of both macrophages and alveolar epithelial cells. Here, we show that treatment with lysophosphatidic acid (LPA) of mice aerogenically infected with MTB immediately after infection results in a significant early reduction of pulmonary CFUs and of histopathological damage in comparison with control mice. In contrast, treatment of acute disease does not result in any improvement of both microbiological and histopathological parameters. Altogether, these results show that LPA treatment can exert protective effect if administrated during primary infection, only.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1-4 |
| Numero di pagine | 4 |
| Rivista | Cellular Immunology |
| Volume | 271 |
| Numero di pubblicazione | 1 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2011 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Immunologia
Keywords
- Acute Disease
- Animals
- Colony Count
- Female
- Inbred BALB C
- Lung
- Lysophospholipids
- Mice
- Microbial
- Mycobacterium tuberculosis
- Pulmonary
- Sphingosine
- Time Factors
- Treatment Outcome
- Tuberculosis
Fingerprint
Entra nei temi di ricerca di 'Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver